
Transforming Biopharma
Transforming Biopharma by ZS dissects the complex world of pharmaceuticals through candid conversations. Hosted by Maria Whitman, Transforming Biopharma by ZS covers a variety of perspectives from industry leaders who are pushing boundaries and redesigning the future.
Transforming Biopharma
‘We can’t do it alone’: UCB’s Colin Lake on partnerships, patients and rare diseases
•
ZS
Colin Lake, VP and head of digital care transformation, neurology and rare disease at UCB, is passionate about helping patients with rare diseases. He joins Maria Whitman to talk about how UCB has focused on simplifying its digital strategy to address key pain points for rare disease patients.
Highlights include:
- Why partnerships are an important part of this journey
- How a collaboration using ZS’s ZEBRA tool helped UCB move the needle of diagnosis
- Why pharma leaders should experiment with new technologies to drive real change and innovation